Catalyst Wire Dossier Catalyst Wire Dossier

toripalimab + temozolomide

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for toripalimab + temozolomide, covering 2023-04-25 to 2023-04-25. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma [Phase 2]

See pricing